> after 30 weeks, patients on Ozempic 0.5mg had lost 2.6 kg more than the placebo group, and patients on Ozempic 1mg lost 3.5 kg more than the placebo group.
That doesn't seem all that much weight loss to me, and it sounds far from being "basically solved".
Also, financing the drug seems to be an unsolved problem, except for the rich.
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.147...
> mean weight loss was 17.3% (SD: 9.3%) with [2.4mg] semaglutide and 2.0% (SD: 6.1%) with placebo
Re financing, they’re incredibly expensive in the US, but in the UK Ozempic ends up being ~£200 a month, and many people seem to find they save that much in food costs. Also this stuff is dead easy to manufacture, every pharma company seems to have their own version in the pipeline, and some of the very first versions (eg liraglutide, from memory) aren’t too far off patent expiry.
Wait a few years for patents to expire (or go grey market with pirated surplus from the factory)